市场调查报告书
商品编码
1541024
2024-2032 年按产品应用、最终用户和地区分類的旋切设备市场报告Atherectomy Devices Market Report by Product Application, End User, and Region 2024-2032 |
IMARC Group年,全球旋切设备市场规模达9.78亿美元。週边动脉疾病(PAD)的增加、重大技术进步、人口老化、微创手术的出现、医疗保健基础设施的发展以及新兴经济体的报销政策是推动斑块切除术市场成长的一些关键因素。
主要市场驱动因素:旋切设备市场受到週边动脉疾病(PAD)和其他心血管疾病病例不断增加的影响。日益增长的老龄化人口更容易患这些疾病,加上糖尿病、肥胖和吸烟病例的增加,正在对这些设备产生间接需求。此外,斑块切除术的技术进步和微创手术的日益普及为市场提供了大量机会。
主要市场趋势:斑块旋切设备市场正在扩大,主要是由于 PAD 病例的增加和微创手术的需求等重大趋势。技术的进步使得能够生产更先进的设备,从而提供更高的准确性和更短的恢復週期。定向粥样斑块切除系统也越来越受欢迎,因为它们允许使用者在不损坏血管壁的情况下瞄准并去除动脉粥状硬化斑块。在新兴经济体,医疗基础设施的发展和更好的报销情况正在推动斑块切除设备在全球范围内的可用性和使用。
竞争格局:斑块切除设备产业的一些主要市场参与者包括 Abbott Laboratories、Avinger、B. Braun Melsungen AG、Biomerics、Biotronik、Boston Scientific Corporation、CR Bard (Becton、Dickinson and Company)、Cardinal Health、Koninklijke Philips NV 、Medtronic、Minnetronix Inc.、Straub Medical AG(Becton、Dickinson and Company)、Terumo Corporation 等。
挑战与机会:旋切设备市场面临多项挑战,包括高昂的设备成本和严格的监管要求,导致产品发布延迟。相反,市场机会也受到週边动脉疾病发病率上升和人口老化的影响,这导致需要有效的治疗替代方案。提高设备性能和安全性的技术发展提供了成长机会。此外,新兴市场医疗保健基础设施的成长创造了新的市场扩张前沿,刺激了全球对斑块旋切手术的需求。
週边动脉疾病 (PAD) 病例不断增加
由于人口老化以及糖尿病和肥胖症的增加,全球 PAD 病例不断增加,导致斑块旋切设备市场成长。在美国,PAD 大约影响 8 至 1,200 万人,尤其是 50 岁以上的人。斑块切除装置提供了一种去除动脉斑块的微创方法,因为它是血管介入治疗的重要替代方案。该装置可增强血液流动并减轻腿部疼痛和疲劳等症状。透过直接切除或蒸发斑块,这些设备有助于恢復动脉通畅,显着改善患有严重週边动脉疾病的患者的治疗效果。
技术进步
主要的旋切设备创新包括定向控制设备和高频旋转技术的出现,这些技术不断提高了这些设备的有效性和安全性。例如,2020 年的一项研究表明,眼眶斑块旋切术(磨碎斑块)可以在90% 的情况下有效地打开阻塞的腿部动脉,而雷射旋切术可以在76% 的情况下实现类似的血流改善。患者治疗效果的改善和外科医生对这些设备的偏好正在推动斑块切除设备的成长。在一项涉及 172 名患者的多中心研究中,使用 Jetstream 设备的成功率为 99%,六个月和 12 个月临床驱动的目标病变血管重建率分别为 15% 和 26%;根据复式成像,一年再狭窄率为 38%。
拓展新兴市场
突出的关键参与者正在关注医疗基础设施发展和医疗保健支出成长的新兴经济体,为市场中的关键参与者创造新的机会。例如,巴西、俄罗斯、印度、中国和南非(金砖五国)等新兴市场正日益影响全球卫生部门医疗产品和服务的供需格局。 2030 年医疗支出占 GDP 的百分比预计为 - 巴西 8.4%;俄罗斯,5.2%;印度,3.5%;中国,5.9%;南非,10.4%。透过实现更先进的治疗替代方案,可以渗透到这些市场,从而扩大斑块切除设备的全球足迹。
IMARC Group提供了对每个细分市场的主要趋势的分析,以及 2024-2032 年全球、区域和国家层面的预测。我们的报告根据产品、应用和最终用户对市场进行了分类。
定向斑块切除装置
眼眶斑块旋切装置
光消融斑块切除装置
旋磨术设备
支援设备
定向旋磨设备占据大部分市场份额
该报告根据产品提供了详细的市场细分和分析。这包括定向斑块切除装置、眼眶斑块切除装置、光消融斑块切除装置、旋转斑块切除装置和支撑装置。根据该报告,定向斑块旋切装置占据了最大的份额。
定向粥样斑块切除装置的创建是为了精确消除阻塞动脉中的动脉粥状硬化斑块。这些仪器提供了精确控制的可能性,从而减少了血管壁创伤,这是患者安全和康復的一个重要方面。它们能够治疗多种血管尺寸的复杂病变,使其受到血管专家的青睐,导致该产品领域的成长。该装置在手术过程中收集和去除牙菌斑的能力使这些装置与众不同,并且在许多临床情况下更受欢迎。
周围血管
心血管
神经血管
週边血管占据大部分市场份额
该报告根据应用程式提供了详细的市场细分和分析。这包括週边血管、心血管和神经血管。根据报告,週边血管占最大部分。
由于 PAD 的盛行率不断增加,使用斑块旋切装置治疗週边血管疾病非常重要。此类装置在重建腿部动脉血流方面发挥关键作用,有助于缓解疼痛和行动问题等症状。此领域的需求取决于手术的微创特性,与传统手术相比,微创手术的恢復期短,併发症的风险较低,进而提高病患的治疗效果和治疗效率。
医院
门诊手术中心
研究实验室和学术机构
医院占大部分市场份额
该报告提供了基于最终用户的详细市场细分和分析。这包括医院、门诊手术中心、研究实验室和学术机构。报告称,医院占最大部分。
医院是斑块切除设备的主要用户,因为这些手术非常复杂,需要先进的基础设施和训练有素的医疗保健专业人员。此细分市场的成长伴随着医院进行的血管手术数量的增长,这得益于对先进技术和医疗服务提供者培训计划的投资。医院提供包括术后要求在内的所有类型护理的能力也有助于使其成为市场的主导主体。
北美洲
美国
加拿大
亚太地区
中国
日本
印度
韩国
澳洲
印尼
其他的
欧洲
德国
法国
英国
义大利
西班牙
俄罗斯
其他的
拉丁美洲
巴西
墨西哥
其他的
中东和非洲
北美市场占据主导地位
该报告还对包括北美(美国、加拿大)在内的所有主要市场进行了全面分析;亚太地区(中国、日本、印度、韩国、澳洲、印尼等);欧洲(德国、法国、英国、义大利、西班牙、俄罗斯等);拉丁美洲(巴西、墨西哥等)、中东和非洲。报告称,北美是旋切设备的最大市场。
由于心血管疾病的高发病率、发达的医疗保健系统以及该地区的主要市场参与者,北美成为旋切术的最大市场。美国因其有利的报销方案、临床试验以及政府对先进医疗设备研发的大力支持而成为该地区最大的市场。该地区对应用新医疗保健解决方案的承诺正在推动市场成长。
市场研究报告也对市场竞争格局进行了全面分析。已提供所有主要公司的详细资料。斑块旋切设备市场的一些主要市场参与者包括Abbott Laboratories、Avinger、B. Braun Melsungen AG、Biomerics、Biotronik、Boston Scientific Corporation、CR Bard(Becton、Dickinson and Company)、Cardinal Health、Koninklijke Philips NV、Medtronic 、 Minnetronix Inc.、Straub Medical AG(Becton、Dickinson and Company)和 Terumo Corporation。
(请注意,这只是关键参与者的部分列表,报告中提供了完整列表。)
斑块切除设备市场充满活力,主要参与者采用不断发展的策略来追求扩大市场份额并满足对微创手术替代方案不断增长的需求。其中一种方法是以技术为导向的,也就是说,公司在研发方面投入了大量资金,以改善其设备,从而变得更有效率、更安全。第二个共同事件是支持知识共享和更好的分销管道的策略联盟和合作。此外,併购很常见,使公司能够扩大其产品组合和地理覆盖范围。监管机构的批准在这里发挥着重要作用,因为这些公司正在努力满足严格的规范,以确保其产品在许多市场的效率和安全性。
2022 年 3 月,贝朗收购了 Intermedt Medizin & Technik GmbH,一家专门从事透析浓缩液製备的公司。
2023 年 11 月,康德乐宣布在美国推出带有 ASSIST 器械袋的 SmartGown EDGE 透气手术衣,旨在为手术团队提供手术室中安全、便捷的器械使用。
The global atherectomy devices market size reached US$ 978.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,476.0 Million by 2032, exhibiting a growth rate (CAGR) of 4.5% during 2024-2032. The rise in peripheral artery disease (PAD), significant technological advancements, rising ageing population, advent of minimally invasive surgeries, development of healthcare infrastructure, and reimbursement policies in emerging economies represent some of the key factors driving the growth of the atherectomy market.
Major Market Drivers: The atherectomy devices market is affected by the increasing cases of peripheral artery disease (PAD) and other cardiovascular diseases. The rising ageing population that is more susceptible to these ailments, along with the rising instances of diabetes, obesity, and smoking, are creating an indirect demand for these devices. Moreover, technological advancements in atherectomy procedures and the growing popularity of minimally invasive surgeries are providing the market with substantial opportunities.
Key Market Trends: The atherectomy devices market is expanding mostly due to significant trends like the increasing cases of PAD and the requirement for minimally invasive surgeries. Advancements in technology enable the production of more advanced devices, which, in turn, give better accuracy and shorter recovery periods. Directional atherectomy systems are also rising in popularity since they allow the user to target and remove atherosclerotic plaque without damaging the vessel wall. In emerging economies, the growth of healthcare infrastructure and better reimbursement situations are propelling atherectomy device availability and usage worldwide.
Competitive Landscape: Some of the major market players in the Atherectomy Devices industry include Abbott Laboratories, Avinger, B. Braun Melsungen AG, Biomerics, Biotronik, Boston Scientific Corporation, C.R. Bard (Becton, Dickinson and Company), Cardinal Health, Koninklijke Philips N.V., Medtronic, Minnetronix Inc., Straub Medical AG (Becton, Dickinson and Company), Terumo Corporation, among many others.
Challenges and Opportunities: The atherectomy devices market suffers from several challenges, including high device costs and tough regulatory requirements that cause delays in product launches. On the contrary, market opportunities are also influenced by the growing incidence of peripheral artery diseases and aging population, which lead to the need for efficacious treatment alternatives. Developments in technology which improve the performance and safety of device provide growth opportunity. In addition, the growth of healthcare infrastructure in the emerging markets creates new fronts of market expansion, which stimulates the worldwide demand for atherectomy procedures.
Rising Cases of Peripheral Artery Disease (PAD)
The increasing cases of PAD at a global level due to ageing population and the rise in diabetes and obesity is leading the atherectomy device market growth. Approximately, PAD affects 8 to 12 million people in the United States, especially in those over 50. Out of these, 6.5 million over the age of 40 are diagnosed with PAD. Atherectomy devices provide a minimally invasive approach to remove arterial plaque as it is an important alternative in vascular interventions. The device enhances blood flow and reduces symptoms such as leg pain and fatigue. By directly cutting away or vaporizing the plaque, these devices help restore arterial patency, significantly improving patient outcomes in individuals with severe forms of PAD.
Technological Advancements
Major atherectomy devices innovations include the appearance of directionally controlled devices and high-frequency rotational technologies, which have continued to improve the effectiveness and safety of these devices. For instance, a 2020 study suggests that orbital atherectomy (which sands down plaque) effectively opens up blocked leg arteries 90 percent of the time, while laser atherectomy achieves similarly improved blood flow 76 percent of the time. These improvements in patient outcome and surgeon preference for these devices are propelling the growth of the atherectomy devices. In a multicenter study of 172 patients, Jetstream use had a 99% device success, and six-month and 12-month clinically-driven, target-lesion revascularization rates of 15% and 26%, respectively; with a one-year restenosis rate of 38% based on duplex imaging.
Expansion into Emerging Markets
Prominent key players are focusing on emerging economies where healthcare infrastructure development and growing healthcare spending is focused, thereby creating new opportunities for the key players in the market. For instance, the emerging markets of Brazil, Russia, India, China, and South Africa (BRICS) are increasingly shaping the landscape of the global health sector demand and supply for medical goods and services. Health spending as a percentage of GDP in 2030 is projected as - Brazil, 8.4%; Russia, 5.2%; India, 3.5%; China, 5.9%; South Africa, 10.4%. The penetration into these markets is enabled by realization of more advanced treatment alternatives, thus expanding the global footprint of atherectomy devices.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional and country levels for 2024-2032. Our report has categorized the market based on product, application, and end user.
Directional Atherectomy Devices
Orbital Atherectomy Devices
Photo-Ablative Atherectomy Devices
Rotational Atherectomy Devices
Support Devices
Directional Atherectomy Devices accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the product. This includes directional atherectomy devices, orbital atherectomy devices, photo-ablative atherectomy devices, rotational atherectomy devices, and support devices. According to the report, directional atherectomy devices represented the largest segment.
Directional atherectomy devices are created to precisely eliminate atherosclerotic plaque from obstructed arteries. These instruments provide the possibility of accurate control, which reduces vessel wall trauma, an important aspect for patient safety and recovery. Their ability to treat complex lesions in multiple vessel sizes makes them to be favoured by vascular specialists leading to the growth of the product segment. The capability of the devices to collect and remove plaque during the procedure sets these devices apart and is in a number of clinical situations preferable.
Peripheral Vascular
Cardiovascular
Neurovascular
Peripheral Vascular accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the application. This includes peripheral vascular, cardiovascular, and neurovascular. According to the report, peripheral vascular represented the largest segment.
The use of atherectomy devices in the treatment of peripheral vascular diseases is important because of the growing prevalence of PAD. Such devices play a key role in reestablishing the blood flow in leg arteries thus help to relieve the symptoms such as pain and mobility problems. The demand in this segment is determined by minimally invasive character of the procedure which allows short recovery period and lower risks of complications in comparison to conventional surgery making patient outcomes and treatment efficiencies higher.
Hospitals
Ambulatory Surgery Centers
Research Laboratories and Academic Institutes
Hospitals accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, ambulatory surgery centers, and research laboratories and academic institutes. According to the report, hospitals represented the largest segment.
Hospitals are the main users of atherectomy devices because these procedures are very complex and need advanced infrastructure and highly trained healthcare professionals. The growth of the segment is followed by the growth of the number of vascular surgeries conducted in hospitals, fueled by investments into advanced technologies and in the training programs of health providers. Ability of hospitals to offer all types of care including post-operative requirements also helps in making them the dominant subject in the market.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America dominates the market
The report has also provided a comprehensive analysis of all the major markets which include North America (United States, Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others); Latin America (Brazil, Mexico, Others), and Middle East and Africa. According to the report, North America was the largest market for atherectomy devices.
North America is the largest market for atherectomy because of high prevalence of cardiovascular diseases, developed healthcare system and the key market players in the region. The United States is the biggest market in this region because of the favourable reimbursement scenarios, clinical trials, and solid governmental support for research and development in advanced medical devices. The commitment of the region to application of new healthcare solutions is driving the market growth.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have been provided. Some of the major market players in the atherectomy devices market include Abbott Laboratories, Avinger, B. Braun Melsungen AG, Biomerics, Biotronik, Boston Scientific Corporation, C.R. Bard (Becton, Dickinson and Company), Cardinal Health, Koninklijke Philips N.V., Medtronic, Minnetronix Inc., Straub Medical AG (Becton, Dickinson and Company), and Terumo Corporation.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
There is a dynamic market in atherectomy devices with the use of evolving strategies by major players in pursuit to grow their market share and to satisfy the increasing demand for minimally invasive surgery alternatives. One of these approaches is technical oriented, which is to say that the companies invest significantly in R&D to improve their devices that become therefore more efficient and safer. The second common event is strategic alliances and collaborations that support knowledge sharing and better distribution channels. In addition, mergers and acquisitions are common enabling companies to expand their product portfolios and geographical coverage. Approvals by regulatory bodies play an important role here as the companies are trying to meet tough norms that guarantee the efficiency and safety of their products in many markets.
In March 2022, B. Braun acquired Intermedt Medizin & Technik GmbH, a specialist in the preparation of dialysis concentrates.
In November 2023, Cardinal Health announced the U.S. launch of its SmartGown EDGE Breathable Surgical Gown with ASSIST Instrument Pockets, created to provide surgical teams safe and convenient instrument access in the operating room.